---
figid: PMC8995459__JCMM-26-2377-g003
pmcid: PMC8995459
image_filename: JCMM-26-2377-g003.jpg
figure_link: /pmc/articles/PMC8995459/figure/jcmm17258-fig-0003/
number: FIGURE 3
figure_title: ''
caption: EZH2 activates autophagy, mTOR and EMT inhibited by MEG3. A, Autophagy marker
  detection in control, MEG3 overexpression, EZH2 rescue and ΔSET EZH2 rescue groups
  of SK‐N‐AS cells; B, Autophagy marker detection in EZH2 knockdown, 48 h EZH2 inhibitor
  DZNep (5 μm and 10 µm) treatment and EZH2 overexpression groups compared to control;
  C, mTOR signalling pathway protein detection in control, MEG3 overexpression, EZH2
  rescue and ΔSET EZH2 rescue groups of SK‐N‐AS cells; D, mTOR signalling pathway
  protein detection in EZH2 knockdown, 48 h EZH2 inhibitor DZNep (5 μm and 10 μm)
  treatment and EZH2 overexpression groups compared with control; E, EMT marker detection
  in control, MEG3 overexpression, EZH2 rescue and ΔSET EZH2 rescue groups of SK‐N‐AS
  cells; F, EMT marker detection in EZH2 knockdown, 48 h EZH2 inhibitor DZNep (5 μm
  and 10 μm) treatment and EZH2 overexpression groups compared with control
article_title: Downregulation of MEG3 and upregulation of EZH2 cooperatively promote
  neuroblastoma progression.
citation: Mujie Ye, et al. J Cell Mol Med. 2022 Apr;26(8):2377-2391.
year: '2022'

doi: 10.1111/jcmm.17258
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- epigenetics
- EZH2
- long non‐coding RNA
- MEG3
- neuroblastoma

---
